Advanced Micro Devices (NASDAQ:AMD) Stock Goes Parabolic: Here is What BofA Securities Saying

Shares of Advanced Micro Devices, Inc. (NASDAQ:AMD) continues to move up and now up by 6% to $119.20 after hitting a new high of $122.49 earlier in the session. BofA’s Vivek Arya highlighted, “We examine Q2 PC/Server CPU trends based on Mercury Research data. Unless specified we are reviewing x86 trends, although we do also analyze Arm units provided by Mercury for the first time in Q1. Q2 CPU sales…

Read More >>

Moderna Inc (NASDAQ:MRNA) Stock Soars Above $400: All Eyes on Earnings Tomorrow

Moderna Inc (NASDAQ:MRNA) will report second quarter earnings tomorrow before the open. There is a conference call scheduled for 8:00 ET. Q2 Capital IQ consensus calls for EPS of $5.86 vs. ($0.31) last year on revenue of $4.233 billion versus $66.3 million last year. The company typically does not provide EPS or revenue guidance. The first area of interest will be the company’s COVID-19 vaccine. The company recently Increased 2021…

Read More >>

Beyondspring Inc (NASDAQ:BYSI) Stock Soars: H.C. Wainwright Upgardes With $100 PT

Shares of Beyondspring Inc (NASDAQ:BYSI) soared 170% to $26.06 after the company announced positive topline data of DUBLIN-3 trial in plinabulin in combination with docetaxel (DP) to treat 2nd and 3rd line NSCLC (EGFR wild type) compared to docetaxel alone (D) (n=559). H.C. Wainwright upgrades BYSI to Buy from Neutral and sets target price at $100. Analyst Joseph Pantginis said, “Dublin-3 provides some beautiful summer fireworks with endpoints met, representing…

Read More >>

Novavax Inc (NASDAQ:NVAX) Stock Jumps Above $200 After The Big News

Novavax Inc (NASDAQ:NVAX) has reached an agreement with the European Commission (EC) for the purchase of up to 200M doses of NVX-CoV2373, the company’s recombinant nanoparticle protein-based COVID-19 vaccine candidate with Matrix-M adjuvant. The agreement covers the purchase of up to 100M doses of the vaccine with the option for an additional 100M doses through 2023. Novavax is working to complete its rolling submission for NVX-CoV2373 to the European Medicines…

Read More >>

Ever-Glory International (NASDAQ:EVK) Stock Buy-Back Program Gave Its Share A Boom

The shares of Ever-Glory International (NASDAQ:EVK), a retailer of branded fashion apparel and a leading global apparel supply chain solution provider, boomed with its announcement of the stock buy back program. Bearing the sweetest fruits to its investors, the investors of the company have fetched remarkable gains to an extent that it has become a “must buy” on the list of several new investors. Being the hyper active stock for…

Read More >>

Analyst Note: NVIDIA Corporation (NASDAQ:NVDA), Chatham Lodging (NYSE:CLDT)

NVIDIA Corporation (NASDAQ:NVDA) target raised to $250 at Rosenblatt (198.15) Rosenblatt raises their NVDA target to $250 from $200. Analyst Hans Mosesmann commented, “We are taking our price target for Buy rated NVDA to $250 from $200 based on earnings power over $6.00 for FY24 (calendar 2023) on best-in-class AI play with growth vectors into next generation networking/DPU adoption and early-days of autonomous driving S/W kicker. We now believe the…

Read More >>

MICT Inc (NASDAQ:MICT) Stock Up Slight After Analyst Note

Shares of MICT Inc (NASDAQ:MICT) are moving up slightly in the pre-market session as analyst at Alliance Global Partners set a price target of $4.25, stating the company is positioned to benefit from surging demand for insurance and equity trading in China. Alliance Global Partners’ Brian Kinstlinger notes, “We expect entry into the Chinese insurance market will be a primary catalyst. Pending launch of Magpie, its online equities trading platform,…

Read More >>

Eco Depot, Inc. (OTCMKTS: ECDP) Up 17% Intraday After News

Eco Depot, Inc. (OTCMKTS:ECDP), an ESG investment opportunity, closed yesterday at $1.54.  The stock opened at $1.595 and reached an intraday high of $1.875 representing a 17% intraday gain, and an almost 90% gain for the stock since it began moving off its low of $1.01 last week.  Naturally, there was some profit-taking. Yesterday’s press release was the second major announcement for ECDP in as many weeks.  In the release,…

Read More >>

MannKind (NASDAQ:MNKD) Stock Sees Buying Interest After An agreement With NRx Pharmaceuticals

NRx Pharmaceuticals (NASDAQ:NRXP) has signed an agreement with MannKind (NASDAQ:MNKD) to develop a dry powder formulation of ZYESAMI (aviptadil), a synthetic form of human Vasoactive Intestinal Peptide (VIP), produced by the body to help protect cells against inflammatory conditions. Development will be based on MannKind’s Technosphere platform, that is the basis of the U.S. FDA-approved Afrezza inhaled insulin product. The investigational drug has demonstrated a greater than 2-fold increased odds…

Read More >>

Aldeyra Therapeutics (NASDAQ:ALDX) Stock Moves Up After The Positive News

Aldeyra Therapeutics (NASDAQ:ALDX) announces that the U.S. FDA has granted orphan drug designation for ADX-2191 (methotrexate for intravitreal injection) for the treatment of retinitis pigmentosa (RP), a group of rare genetic eye diseases. Shares up more than 6% premarket. There are no approved drug treatments for patients with RP, which is a disease affects an estimated 82,000-110,000 individuals in the United States. The FDA’s orphan drug designation program is designed…

Read More >>
x